Please rate this video

BSH/ISH 2016 | The importance of diagnostic testing in CLL

Please rate this video

Anna Schuh

Anna Schuh, MD, PhD, from the University of Oxford, discusses the importance of genomic analysis in chronic lymphocytic leukemia (CLL) in the clinic. According to Dr Schuh, the mutation analysis of TP53 in addition to a FISH analysis are important. She further discusses which other markers will become relevant in the future, which includes looking for subclonal TP53 mutations with next-generation sequencing (NGS) and whole genome sequencing.
Recorded at the 2016 Annual Meeting of the British Society of Haematology (BSH) and International Society of Hematology (ISH), held in Glasgow, Scotland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter